NAP
UTHR icon

New Amsterdam Partners’s United Therapeutics UTHR Stock Holding History

New Amsterdam Partners’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.29M Sell
11,007
-944
-8% -$110K 0.47% 66
2018
Q4 		$1.3M Sell
11,951
-1,413
-11% -$164K 0.43% 74
2018
Q3 		$1.71M Sell
13,364
-284
-2% -$35.1K 0.44% 78
2018
Q2 		$1.54M Sell
13,648
-661
-5% -$72.7K 0.37% 82
2018
Q1 		$1.61M Sell
14,309
-19,543
-58% -$2.48M 0.35% 80
2017
Q4 		$5.01M Sell
33,852
-882
-3% -$112K 1% 45
2017
Q3 		$4.07M Sell
34,734
-3,277
-9% -$418K 0.85% 48
2017
Q2 		$4.93M Sell
38,011
-760
-2% -$94.8K 1.05% 43
2017
Q1 		$5.25M Sell
38,771
-2,355
-6% -$357K 1.24% 26
2016
Q4 		$5.9M Sell
41,126
-5,282
-11% -$674K 1.34% 26
2016
Q3 		$5.48M Buy
46,408
+4,139
+10% +$497K 1.26% 30
2016
Q2 		$4.48M Buy
42,269
+8,496
+25% +$948K 1.09% 39
2016
Q1 		$3.76M Buy
33,773
+4,758
+16% +$602K 0.39% 70
2015
Q4 		$4.54M Sell
29,015
-78,451
-73% -$11.4M 0.47% 63
2015
Q3 		$14.1M Sell
107,466
-10,606
-9% -$1.7M 1.43% 33
2015
Q2 		$20.5M Buy
118,072
+3,696
+3% +$665K 1.77% 27
2015
Q1 		$19.7M Sell
114,376
-43,815
-28% -$6.68M 1.59% 29
2014
Q4 		$20.5M Sell
158,191
-176,076
-53% -$22.7M 1.78% 20
2014
Q3 		$43M Buy
334,267
+57,756
+21% +$5.95M 2.88% 1
2014
Q2 		$24.5M Sell
276,511
-32,445
-11% -$3.12M 1.59% 26
2014
Q1 		$29.1M Buy
+308,956
New +$31.6M 1.99% 20
2013
Q4 		– Sell
-409,762
Closed -$32.3M – 138
2013
Q3 		$32.3M Buy
409,762
+3,437
+0.8% +$251K 2.16% 14
2013
Q2 		$26.7M Buy
+406,325
New +$26.2M 1.43% 22

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

New Amsterdam Partners's UTHR Position: Q1 2019 in Review

New Amsterdam Partners reduced its United Therapeutics (UTHR) stake by 7.9% in Q1 2019, selling an estimated $110K and leaving 11,007 shares worth $1.29M. The position accounts for 0.47% of the portfolio, ranked #66.

New Amsterdam Partners first reported a position in UTHR in Q2 2013 and has held it in 23 quarters since. The position peaked at $43M in Q3 2014. 378 funds tracked by Wall St. Rank hold UTHR as of Q1 2019.

  • New Amsterdam Partners held 11,007 shares of United Therapeutics worth $1.29M as of Q1 2019.
  • New Amsterdam Partners sold 944 United Therapeutics shares in Q1 2019, an estimated $110K.
  • United Therapeutics made up 0.47% of New Amsterdam Partners's portfolio in Q1 2019, its #66 holding.
  • New Amsterdam Partners first reported a position in United Therapeutics in Q2 2013 and has held it in 23 quarters since.
  • New Amsterdam Partners's United Therapeutics position peaked at $43M in Q3 2014.
  • 378 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2019.

Based on New Amsterdam Partners's 13F filing for Q1 2019, filed 2 May 2019.